IDH2 and glioblastoma: The latter two particularly determine the grading of glioblastoma as a WHO grade 4 diffuse glioma and are still considered as valuable as molecular features to confirm a glioblastoma diagnosis in an IDH-wildtype diffuse glioma [6].